Nippon Becton Dickinson's flu test receives Japanese approval:
This article was originally published in Clinica
Nippon Becton Dickinson has received approval to market its Directigen Flu A test in Japan. The product uses monoclonal antibodies to diagnose type-A influenza in approximately 10 minutes and is designed for increased sensitivity and ease of use, says the company. The conventional diagnostic method for type-A influenza takes one to two weeks.
You may also be interested in...
Business development leaders and venture capital investors spoke at Biocom’s annual partnering conference about what they are seeking in relationships with entrepreneurs and start-ups.
Mylan’s full year 2019 earnings report was its last as an independent company, so the focus was on the coming merger with Pfizer’s Upjohn and growth prospects for the new company, Viatris.
Colgate Zero toothpastes and mouthwashes promote what’s missing; Tom’s of Maine natural personal care expands with prebiotic toothpaste, deodorant and hand soap; Gaia adds hemp to its herbs; and Church & Dwight goes environmentally friendly with VitaFusion Goodness supplements, adds CBD versions to line, too.